Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yangzhou Caohejing Pharmaceutical Technology Co., Ltd. is a specialized pharmaceutical company based in Yangzhou, China, focused on the development and production of high-end chemical drugs. The company operates within the Yangzhou Caohejing Hi-Tech Park and maintains a robust portfolio centered on anti-infectives, gastrointestinal treatments, and oncology supportive care. Key commercial products include cefozopran hydrochloride for severe infections and prucalopride succinate for chronic constipation. Yangzhou Caohejing integrates R&D with large-scale manufacturing, utilizing GMP-certified facilities to ensure high-quality standards for both active pharmaceutical ingredients (APIs) and finished preparations. The firm is recognized as a National High-tech Enterprise, reflecting its commitment to innovation in the Chinese domestic market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yangzhou Caohejing Pharmaceutical.